WRBY stock icon

Warby Parker
WRBY

$16.19
3.65%
 

About: Warby Parker Inc is engaged in designing and developing designer prescription glasses and contacts, and providing the facility of eye exams and vision tests. The company predominantly derives revenue from the sales of eyewear products, optical services, and accessories. The firm sells products and services through its stores, website, and mobile apps. Revenue generated from eyewear products includes the sales of prescription and non-prescription optical glasses and sunglasses, contact lenses, eyewear accessories, and expedited shipping charges.

Employees: 3,491

0
Funds holding %
of 6,702 funds
0
Analysts bullish %
of 7 analysts
News positive %

Fund manager confidence

Based on 2024 Q1 SEC filings by fund managers ($100M+ AUM)

12% more repeat investments, than reductions

Existing positions increased: 58 | Existing positions reduced: 52

0.18% more ownership

Funds ownership: 93.38% [Q4 2023] → 93.56% (+0.18%) [Q1 2024]

3% less capital invested

Capital invested by funds: $1.29B [Q4 2023] → $1.25B (-$37.1M) [Q1 2024]

3% less funds holding

Funds holding: 172 [Q4 2023] → 166 (-6) [Q1 2024]

21% less first-time investments, than exits

New positions opened: 23 | Existing positions closed: 29

25% less funds holding in top 10

Funds holding in top 10: 4 [Q4 2023] → 3 (-1) [Q1 2024]

70% less call options, than puts

Call options by funds: $7.25M | Put options by funds: $24.3M

Research analyst outlook

7 Wall Street Analysts provided 1 year price forecasts over the past 6 months

Low target
$13
20%
downside
Avg. target
$16.43
1%
upside
High target
$19
17%
upside

7 analyst ratings

positive
43%
neutral
57%
negative
0%
Loop Capital
Anthony Chukumba
1%downside
$16
Hold
Maintained
10 Jul 2024
UBS
Mark Carden
7%downside
$15
Neutral
Maintained
10 May 2024
Morgan Stanley
Kimberly Greenberger
14%downside
$14
Equal-Weight
Maintained
10 May 2024
Telsey Advisory Group
Dana Telsey
17%upside
$19
Outperform
Maintained
9 May 2024
Telsey Advisory Group
Dana Telsey
17%upside
$19
Outperform
Reiterated
28 Feb 2024

Financial journalist opinion